Samsung Biologics Introduces Optimized Manufacturing Framework, ExellenS™
Prnewswire·2025-10-09 11:00
, /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), today unveiled ExellenSÂ – an optimized manufacturing framework applied across the company's biomanufacturing network. Developed through Samsung Biologics' cumulative expertise in plant design, digitalization, and operational excellence, ExellenSstandardizes equipment, processes, and functional specifications to ensure that every facility operates with the same precision. The framework ...